학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 549건 | 목록 1~20
Academic Journal
Pilati D; Interdisciplinary Nanoscience Center (iNANO), Department of Molecular Biology and Genetics, Aarhus University, DK-8000 Aarhus C, Denmark.; Agyei EK; Interdisciplinary Nanoscience Center (iNANO), Department of Molecular Biology and Genetics, Aarhus University, DK-8000 Aarhus C, Denmark.; Elkhashab M; Interdisciplinary Nanoscience Center (iNANO), Department of Molecular Biology and Genetics, Aarhus University, DK-8000 Aarhus C, Denmark.; Fuchs E; Interdisciplinary Nanoscience Center (iNANO), Department of Molecular Biology and Genetics, Aarhus University, DK-8000 Aarhus C, Denmark.; Nielsen IH; Department of Biomedicine, Aarhus University, Aarhus C, Denmark.; Bjerg TW; Department of Biomedicine, Aarhus University, Aarhus C, Denmark.; Anthi AK; Department of Immunology, Oslo University Hospital Rikshospitalet, Oslo, Norway; Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital Rikshospitalet, Oslo, Norway; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, Norway.; Jiménez-Reinoso A; Immuno-Oncology and Immunotherapy Group, Biomedical Research Institute Hospital Universitario 12 de Octubre (imas12), Madrid, Spain; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain; CNIO-HMRIB Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Hospital del Mar Research Institute Barcelona (HMRIB), Madrid/Barcelona, Spain.; Iversen MB; Department of Biomedicine, Aarhus University, Aarhus C, Denmark.; Pohl L; Department of Biomedicine, Aarhus University, Aarhus C, Denmark.; Narita R; Department of Biomedicine, Aarhus University, Aarhus C, Denmark.; Frago S; Leadartis, S.L., Madrid, Spain.; Jakobsen MR; Department of Biomedicine, Aarhus University, Aarhus C, Denmark.; Andersen JT; Department of Immunology, Oslo University Hospital Rikshospitalet, Oslo, Norway; Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital Rikshospitalet, Oslo, Norway; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, Norway.; Degn SE; Department of Biomedicine, Aarhus University, Aarhus C, Denmark.; Paludan SR; Department of Biomedicine, Aarhus University, Aarhus C, Denmark.; Alvarez-Vallina L; Immuno-Oncology and Immunotherapy Group, Biomedical Research Institute Hospital Universitario 12 de Octubre (imas12), Madrid, Spain; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain; CNIO-HMRIB Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Hospital del Mar Research Institute Barcelona (HMRIB), Madrid/Barcelona, Spain; Leadartis, S.L., Madrid, Spain; Banc de Sang i Teixits (BST), Barcelona, Spain.; Howard KA; Interdisciplinary Nanoscience Center (iNANO), Department of Molecular Biology and Genetics, Aarhus University, DK-8000 Aarhus C, Denmark. Electronic address: kenh@inano.au.dk.
Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1083-351X (Electronic) Linking ISSN: 00219258 NLM ISO Abbreviation: J Biol Chem Subsets: MEDLINE
Academic Journal
IEEE Transactions on Antennas and Propagation IEEE Trans. Antennas Propagat. Antennas and Propagation, IEEE Transactions on. 71(4):2930-2937 Apr, 2023
Academic Journal
Battistini E; Department of Pharmacology, Pharmacy, and Pharmaceutical Technology, School of Pharmacy/Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Lapuhs P; Department of Pharmacology, Pharmacy, and Pharmaceutical Technology, School of Pharmacy/Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Jiménez A; Department of Pharmacology, Pharmacy, and Pharmaceutical Technology, School of Pharmacy/Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Advanced Therapies Manufacturing Center, Galaria EPSS SA, Santiago de Compostela, Spain.; Garrido-Areal S; Department of Pharmacology, Pharmacy, and Pharmaceutical Technology, School of Pharmacy/Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Rivas-Gómez L; Cancer Immunotherapy Unit (UNICA), Immuno-oncology and Immunotherapy Group, Biomedical Research Institute H12O/H12O-CNIO Cancer Immunotherapy Clinical Research Unit/CNIO-HMRIB Cancer Immunotherapy Clinical Research Unit, Hospital Universitario 12 de Octubre (H12O), Spanish National Cancer Research Centre (CNIO), Hospital del Mar Research Institute Barcelona (HMRIB), Madrid & Barcelona, Spain.; Zagorac I; Cancer Immunotherapy Unit (UNICA), Immuno-oncology and Immunotherapy Group, Biomedical Research Institute H12O/H12O-CNIO Cancer Immunotherapy Clinical Research Unit/CNIO-HMRIB Cancer Immunotherapy Clinical Research Unit, Hospital Universitario 12 de Octubre (H12O), Spanish National Cancer Research Centre (CNIO), Hospital del Mar Research Institute Barcelona (HMRIB), Madrid & Barcelona, Spain.; Álvarez-Vallina L; Cancer Immunotherapy Unit (UNICA), Immuno-oncology and Immunotherapy Group, Biomedical Research Institute H12O/H12O-CNIO Cancer Immunotherapy Clinical Research Unit/CNIO-HMRIB Cancer Immunotherapy Clinical Research Unit, Hospital Universitario 12 de Octubre (H12O), Spanish National Cancer Research Centre (CNIO), Hospital del Mar Research Institute Barcelona (HMRIB), Madrid & Barcelona, Spain.; Banc de Sang i Teixits, Barcelona, Spain.; Alonso MJ; Department of Pharmacology, Pharmacy, and Pharmaceutical Technology, School of Pharmacy/Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Madrid Institute for Advanced Studies in Nanoscience, IMDEA Nanociencia, Madrid, Spain.; Sanjurjo L; Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain. lucia.sanjurjo.bouza@sergas.es.
Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE
Academic Journal
Delios, A.Clemente, E. G.Wu, T.Tan, H.Wang, Y.Gordon, M.Viganola, D.Chen, Z.Dreber, A.Johannesson, M.Pfeiffer, T.Uhlmann, E. L.Al-Aziz, A. M. A.Abraham, A. T.Trojan, J.Adamkovic, M.Agadullina, E.Ahn, J.Akinci, C.Akkas, H.Albrecht, D.Alzahawi, S.Amaral-Baptista, M.Anand, R.Ang, K. F. U.Anseel, F.Aruta, J. J. B. R.Ashraf, M.Baker, B. J.Bao, X.Baskin, E.Bathula, H.Bauman, C. W.Bavolar, J.Bayraktar, S.Beckman, S. E.Benjamin, A. S.Brown, S. E. V.Buckley, Jeffrey, 1992; Buitrago, R. E.Bution, J. L.Byrd, N.Carrera, C.Caruso, E. M.Chen, M.Chen, L.Cicerali, E. E.Cohen, E. D.Crede, M.Cummins, J.Dahlander, L.Daniels, D. P.Daskalo, L. L.Dawson, I. G. J.Day, M. V.Dietl, E.Domurat, A.Dsilva, J.Du Plessis, C.Dubrov, D. I.Edris, S.Elbaek, C. T.Elsherif, M. M.Evans, T. R.Fellenz, M. R.Fiedler, S.Firat, M.Freitag, R.Furrer, R. A.Gautam, R.Gautam, D. K.Gearin, B.Gerschewski, S.Ghasemi, O.Ghasemi, Z.Ghosh, A.Giani, C.Goldberg, M. H.Goswami, M.Graf-Vlachy, L.Rajeshwari, H.Griffith, J. A.Grigoryev, D.Gu, J.Hadida, A. L.Hafenbrack, A. C.Hafenbrädl, S.Hammersley, J. J.Han, H.Harman, J. L.Hartanto, A.Henkel, A. P.Ho, Y. -CHolding, B. C.Holzmeister, F.Horobet, A.Huang, T. S. -THuang, Y.Huntsinger, J. R.Idzikowska, K.Imada, H.Imran, R.Ingels, M. J.Jaeger, B.Janssen, S. M. J.Jia, F.Jiménez, A.Jin, J. L.Johannes, N.Jolles, D.Jozefiakova, B.Kačmár, P.Kalandadze, T.Kalimeri, K.Kang, P.Kantorowicz, J.Karada, D.Karimi-Rouzbahani, H.Kee, D. M. H.Keller, L.Khan, H. A.Knutsson, M.Kombeiz, O.Korniychuk, A.Kowal, M.Leder, J.Liang, L. W.Liew, T.Lin, F.Liu, C.Liu, B.Longo, M. C.Lovakov, A.Low, M. P.Lucas, G. J. M.Lukason, O.Ly, A. L.Ma, Z.Mafael, A.Mahmoudkalayeh, S.Manheim, D.Marcus, A.Marsh, M. S.Martin, J. M.Martinez, L. E.Martinoli, M.Martončik, M.Masters-Waage, T. C.Mata, R.Mazloomi, H.Mccarthy, R. J.Millroth, P.Mishra, M.Mishra, S.Mohr, A.Moreau, D.Myer, A.Nadler, A.Nair, S.Nilsonne, G.Niszczota, P.O'Mahony, A.Oberhauser, M.Obloj, T.Orhan, M. A.Oswald, F.Otterbring, T.Otto, P. E.Padrón-Hernández, I.Pan, A. J.Paruzel-Czachura, M.Pfuhl, G.Pirrone, A.Porcher, S.Protzko, J.Qi, S.Rahal, R. -MRahman, Md.S.Reina, M. L.Rentala, S.Riaz, Z.Ropovik, I.Röseler, L.Ross, R. M.Rotella, A.Roth, L. H. O.Roulet, T. J.Rubin, M. M.Sammartino, A.Sanchez, J.Saville, A. D.Schaerer, M.Schleu, J. E.Schmallenbach, L.Schnabel, L.Spüntrup, F. S.Schumpe, B. M.Senanayake, T.Seri, R.Sheng, F.Snider, R. E.Song, D.Song, V.Starnawska, S. E.Stern, K. A.Stevens, S. M.Strømland, E.Su, W.Sun, H.Sweeney, K. P.Takamatsu, R.Terskova, M.Tey, K. S.Tierney, W.Todorova, M. M.Tolstoy, D.Torkkeli, L.Tybur, J. M.Valderrey, F. J.Vallina-Hernandez, A. M.Vasudevan, R. P.Rao, G. V.Vernet, A.Vissak, T.Voss, H.Wahle, T.Wai, J.Wakabayashi, L. E. T.Wang, J.Wang, P.Warmenhoven, R. W.Wennberg, K.Wernicke, G.Woike, J. K.Wollbrant, C. E.Woodin, G.Wright, J. D.Xia, Q.Xie, Z.Yoon, S.Yuan, W.Yuan, L.Yucel, M.Zheng, Z.Zhou, H.Zogmaister, C.Zultan, R.Collaboration, Generalizability Tests Forecasting
Proceedings of the National Academy of Sciences of the United States of America. 119(30)
Academic Journal
Gómez-Rosel M; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; CNIO-HMRIB Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Hospital del Mar Research Institute Barcelona (HMRIB), Spain.; Department of Antibody Engineering, Leadartis SL, QUBE Technology Park, Tres Cantos, Madrid, Spain.; Rubio-Pérez L; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; CNIO-HMRIB Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Hospital del Mar Research Institute Barcelona (HMRIB), Spain.; Zagorac I; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; CNIO-HMRIB Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Hospital del Mar Research Institute Barcelona (HMRIB), Spain.; Domínguez-Alonso C; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; CNIO-HMRIB Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Hospital del Mar Research Institute Barcelona (HMRIB), Spain.; Díez-Alonso L; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; CNIO-HMRIB Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Hospital del Mar Research Institute Barcelona (HMRIB), Spain.; Hangiu O; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Department of Antibody Engineering, Leadartis SL, QUBE Technology Park, Tres Cantos, Madrid, Spain.; Navarro R; Department of Antibody Engineering, Leadartis SL, QUBE Technology Park, Tres Cantos, Madrid, Spain.; Torres-Ruíz R; Molecular Cytogenetics Group, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Rodríguez-Perales S; Molecular Cytogenetics Group, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Blanco FJ; Instituto de Biomedicina de Valencia (IBV), CSIC, Valencia, Spain.; Centro de Investigación Príncipe Felipe (CIPF), Unidad Asociada a IBV, Valencia, Spain.; Compte M; Department of Antibody Engineering, Leadartis SL, QUBE Technology Park, Tres Cantos, Madrid, Spain.; Álvarez-Vallina L; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; CNIO-HMRIB Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Hospital del Mar Research Institute Barcelona (HMRIB), Spain.; Banc de Sang i Teixits, Barcelona, Spain.; Blanco B; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; CNIO-HMRIB Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Hospital del Mar Research Institute Barcelona (HMRIB), Spain.; Departamento de Desarrollo de Medicamentos de Terapias Avanzadas, Instituto de Salud Carlos III, Madrid, Spain.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Conference
2019 13th European Conference on Antennas and Propagation (EuCAP) Antennas and Propagation (EuCAP), 2019 13th European Conference on. :1-5 Mar, 2019
Academic Journal
Zagorac I; Cancer Immunotherapy Unit, Department of Immunology, Hospital Universitario12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Centro Nacional de Investigaciones Oncológicas-Hospital del Mar Research Institute Barcelona (CNIO-HMRIB) Cancer Immunotherapy Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Ramírez-Fernández Á; Cancer Immunotherapy Unit, Department of Immunology, Hospital Universitario12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Tapia-Galisteo A; Cancer Immunotherapy Unit, Department of Immunology, Hospital Universitario12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Centro Nacional de Investigaciones Oncológicas-Hospital del Mar Research Institute Barcelona (CNIO-HMRIB) Cancer Immunotherapy Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Rubio-Pérez L; Cancer Immunotherapy Unit, Department of Immunology, Hospital Universitario12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Centro Nacional de Investigaciones Oncológicas-Hospital del Mar Research Institute Barcelona (CNIO-HMRIB) Cancer Immunotherapy Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Gómez-Rosel M; Cancer Immunotherapy Unit, Department of Immunology, Hospital Universitario12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Centro Nacional de Investigaciones Oncológicas-Hospital del Mar Research Institute Barcelona (CNIO-HMRIB) Cancer Immunotherapy Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Grau M; Animal Facility, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Rodríguez-Peralto JL; Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Pathology, Universidad Complutense, Madrid, Spain.; Cutaneous Oncology Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Centro de Investigación Biomédica en Red en Oncología (CIBERONC), Madrid, Spain.; Álvarez-Vallina L; Cancer Immunotherapy Unit, Department of Immunology, Hospital Universitario12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Centro Nacional de Investigaciones Oncológicas-Hospital del Mar Research Institute Barcelona (CNIO-HMRIB) Cancer Immunotherapy Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Banc de Sang i Teixits, Barcelona, Spain.; Blanco B; Cancer Immunotherapy Unit, Department of Immunology, Hospital Universitario12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Centro Nacional de Investigaciones Oncológicas-Hospital del Mar Research Institute Barcelona (CNIO-HMRIB) Cancer Immunotherapy Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III, Madrid, Spain.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Conference
IMDEA Networks Institute Digital Repository
instname
IMDEA Networks Institute
Academic Journal
Annuarium Historiae Conciliorum. 45:115-218
Academic Journal
Docta Complutense
instname
Cuesta, À M, Suárez, E, Larsen, M, Jensen, K B, Sanz, L, Compte, M, Kristensen, P & Álvarez-Vallina, L 2006, 'Enhancement of DNA vaccine potency through linkage of antigen to filamentous bacteriophage coat protein III domain I', Immunology, vol. 117, no. 4, pp. 502–506. https://doi.org/10.1111/j.1365-2567.2006.02325.x
Cuesta, À M, Suárez, E, Larsen, M, Jensen, K B, Sanz, L, Compte, M, Kristensen, P & Álvarez-Vallina, L 2006, 'Enhancement of DNA vaccine potency through linkage of antigen to filamentous bacteriophage coat protein III domain I', Immunologiya, vol. 117, no. 4, pp. 502-506.
검색 결과 제한하기
제한된 항목
[검색어] Vallinas, I.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어